{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T03:55:14Z","timestamp":1769918114795,"version":"3.49.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T00:00:00Z","timestamp":1499904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T00:00:00Z","timestamp":1499904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL112597"],"award-info":[{"award-number":["R01HL112597"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL116042"],"award-info":[{"award-number":["R01 HL116042"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL120659"],"award-info":[{"award-number":["R01 HL120659"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s13346-017-0409-0","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T14:49:30Z","timestamp":1499957370000},"page":"918-927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine"],"prefix":"10.1007","volume":"8","author":[{"given":"Sannette","family":"Hall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devendra K.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,13]]},"reference":[{"key":"409_CR1","unstructured":"Writing Group Members, Mozaffarian D, Benjamin EJ et al. Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association. Circulation. 133(4), e38\u2013360 (2016)."},{"issue":"8 Suppl","key":"409_CR2","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","volume":"47","author":"E Falk","year":"2006","unstructured":"Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47(8 Suppl):C7\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"409_CR3","doi-asserted-by":"crossref","unstructured":"Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell. 104(4), 503\u2013516 (2001).","DOI":"10.1016\/S0092-8674(01)00238-0"},{"issue":"6","key":"409_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.hlc.2013.03.001","volume":"22","author":"K Sakakura","year":"2013","unstructured":"Sakakura K, Nakano M, Otsuka F, Ladich E, Kolodgie FD, Virmani R. Pathophysiology of atherosclerosis plaque progression. Heart Lung Circ. 2013;22(6):399\u2013411.","journal-title":"Heart Lung Circ"},{"issue":"12","key":"409_CR5","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","volume":"114","author":"JF Bentzon","year":"2014","unstructured":"Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114(12):1852\u201366.","journal-title":"Circ Res"},{"issue":"22","key":"409_CR6","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1161\/CIRCULATIONAHA.105.540013","volume":"114","author":"S Waxman","year":"2006","unstructured":"Waxman S, Ishibashi F, Muller JE. Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events. Circulation. 2006;114(22):2390\u2013411.","journal-title":"Circulation"},{"key":"409_CR7","doi-asserted-by":"crossref","unstructured":"Bergheanu SC, Bodde MC, Jukema JW. Pathophysiology and treatment of atherosclerosis: current view and future perspective on lipoprotein modification treatment. Neth Heart J. 2017;","DOI":"10.1007\/s12471-017-0959-2"},{"issue":"2","key":"409_CR8","first-page":"105","volume":"10","author":"H Hamid","year":"2007","unstructured":"Hamid H, Coltart J. \u2018Miracle stents\u2019\u2014a future without restenosis. Mcgill J Med. 2007;10(2):105\u201311.","journal-title":"Mcgill J Med"},{"issue":"6","key":"409_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/cts.12186","volume":"7","author":"K Yin","year":"2014","unstructured":"Yin K, Agrawal DK. High-density lipoprotein: a novel target for antirestenosis therapy. Clin Transl Sci. 2014;7(6):500\u201311.","journal-title":"Clin Transl Sci"},{"issue":"2","key":"409_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/jbm.b.30974","volume":"85","author":"A Kraitzer","year":"2008","unstructured":"Kraitzer A, Kloog Y, Zilberman M. Approaches for prevention of restenosis. J Biomed Mater Res B Appl Biomater. 2008;85(2):583\u2013603.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"1","key":"409_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/01926230500499407","volume":"34","author":"AG Touchard","year":"2006","unstructured":"Touchard AG, Schwartz RS. Preclinical restenosis models: challenges and successes. Toxicol Pathol. 2006;34(1):11\u20138.","journal-title":"Toxicol Pathol"},{"issue":"2","key":"409_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/path.4646","volume":"238","author":"J Shim","year":"2016","unstructured":"Shim J, Al-Mashhadi RH, Sorensen CB, Bentzon JF. Large animal models of atherosclerosis\u2014new tools for persistent problems in cardiovascular medicine. J Pathol. 2016;238(2):257\u201366.","journal-title":"J Pathol"},{"key":"409_CR13","first-page":"227","volume":"6","author":"A Santos","year":"2015","unstructured":"Santos A, Fernandez-Friera L, Villalba M, et al. Cardiovascular imaging: what have we learned from animal models? Front Pharmacol. 2015;6:227.","journal-title":"Front Pharmacol"},{"issue":"1","key":"409_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cjca.2013.09.012","volume":"30","author":"T Simard","year":"2014","unstructured":"Simard T, Hibbert B, Ramirez FD, Froeschl M, Chen YX, O'Brien ER. The evolution of coronary stents: a brief review. Can J Cardiol. 2014;30(1):35\u201345.","journal-title":"Can J Cardiol"},{"issue":"2","key":"409_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/cvr\/cvt115","volume":"99","author":"C Chaabane","year":"2013","unstructured":"Chaabane C, Otsuka F, Virmani R, Bochaton-Piallat ML. Biological responses in stented arteries. Cardiovasc Res. 2013;99(2):353\u201363.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"409_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.7150\/thno.7210","volume":"4","author":"RX Yin","year":"2014","unstructured":"Yin RX, Yang DZ, Wu JZ. Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis. Theranostics. 2014;4(2):175\u2013200.","journal-title":"Theranostics"},{"issue":"1","key":"409_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4068\/cmj.2017.53.1.14","volume":"53","author":"KM Lekshmi","year":"2017","unstructured":"Lekshmi KM, Che HL, Cho CS, Park IK. Drug- and gene-eluting stents for preventing coronary restenosis. Chonnam Med J. 2017;53(1):14\u201327.","journal-title":"Chonnam Med J"},{"issue":"2","key":"409_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1155\/S1110724303209086","volume":"2003","author":"KL Dishart","year":"2003","unstructured":"Dishart KL, Work LM, Denby L, Baker AH. Gene therapy for cardiovascular disease. J Biomed Biotechnol. 2003;2003(2):138\u201348.","journal-title":"J Biomed Biotechnol"},{"issue":"4","key":"409_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000119","volume":"2","author":"JA Wolfram","year":"2013","unstructured":"Wolfram JA, Donahue JK. Gene therapy to treat cardiovascular disease. J Am Heart Assoc. 2013;2(4):e000119.","journal-title":"J Am Heart Assoc"},{"issue":"2\u20133","key":"409_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.pbiomolbio.2003.11.006","volume":"84","author":"AH Baker","year":"2004","unstructured":"Baker AH. Designing gene delivery vectors for cardiovascular gene therapy. Prog Biophys Mol Biol. 2004;84(2\u20133):279\u201399.","journal-title":"Prog Biophys Mol Biol"},{"issue":"6","key":"409_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/CRD.0b013e31828c5ced","volume":"21","author":"DA Chistiakov","year":"2013","unstructured":"Chistiakov DA, Sobenin IA, Orekhov AN. Vascular extracellular matrix in atherosclerosis. Cardiol Rev. 2013;21(6):270\u201388.","journal-title":"Cardiol Rev"},{"issue":"3","key":"409_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/cvr\/cvs276","volume":"96","author":"SA Goel","year":"2012","unstructured":"Goel SA, Guo LW, Liu B, Kent KC. Mechanisms of post-intervention arterial remodelling. Cardiovasc Res. 2012;96(3):363\u201371.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"409_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.vph.2012.10.008","volume":"58","author":"AC Bradshaw","year":"2013","unstructured":"Bradshaw AC, Baker AH. Gene therapy for cardiovascular disease: perspectives and potential. Vasc Pharmacol. 2013;58(3):174\u201381.","journal-title":"Vasc Pharmacol"},{"issue":"6","key":"409_CR24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.avsg.2011.02.026","volume":"25","author":"EE Joviliano","year":"2011","unstructured":"Joviliano EE, Piccinato CE, Dellalibera-Joviliano R, Moriya T, Evora PR. Inflammatory markers and restenosis in peripheral percutaneous angioplasty with intravascular stenting: current concepts. Ann Vasc Surg. 2011;25(6):846\u201355.","journal-title":"Ann Vasc Surg"},{"key":"409_CR25","doi-asserted-by":"crossref","unstructured":"Hamamdzic D, Wilensky RL. Porcine models of accelerated coronary atherosclerosis: role of diabetes mellitus and hypercholesterolemia. J Diabetes Res. 2013;2013(761415)","DOI":"10.1155\/2013\/761415"},{"issue":"2","key":"409_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cardiores.2007.02.012","volume":"74","author":"R Khan","year":"2007","unstructured":"Khan R, Agrotis A, Bobik A. Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury. Cardiovasc Res. 2007;74(2):223\u201334.","journal-title":"Cardiovasc Res"},{"issue":"22","key":"409_CR27","doi-asserted-by":"publisher","first-page":"10759","DOI":"10.1073\/pnas.90.22.10759","volume":"90","author":"EG Nabel","year":"1993","unstructured":"Nabel EG, Shum L, Pompili VJ, et al. Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A. 1993;90(22):10759\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"409_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0008-6363(01)00199-7","volume":"50","author":"J Chamberlain","year":"2001","unstructured":"Chamberlain J, Gunn J, Francis SE, et al. TGFbeta is active, and correlates with activators of TGFbeta, following porcine coronary angioplasty. Cardiovasc Res. 2001;50(1):125\u201336.","journal-title":"Cardiovasc Res"},{"issue":"21","key":"409_CR29","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1161\/hc4601.099405","volume":"104","author":"PA Kingston","year":"2001","unstructured":"Kingston PA, Sinha S, David A, Castro MG, Lowenstein PR, Heagerty AM. Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition. Circulation. 2001;104(21):2595\u2013601.","journal-title":"Circulation"},{"issue":"22","key":"409_CR30","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1161\/01.CIR.0000097068.49080.A0","volume":"108","author":"PA Kingston","year":"2003","unstructured":"Kingston PA, Sinha S, Appleby CE, et al. Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty. Circulation. 2003;108(22):2819\u201325.","journal-title":"Circulation"},{"issue":"4","key":"409_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/emm.2002.42","volume":"34","author":"IM Chung","year":"2002","unstructured":"Chung IM, Ueno H, Pak YK, et al. Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications. Exp Mol Med. 2002;34(4):299\u2013307.","journal-title":"Exp Mol Med"},{"issue":"3","key":"409_CR32","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ijcard.2009.11.032","volume":"145","author":"IM Chung","year":"2010","unstructured":"Chung IM, Kim J, Pak YK, et al. Blockade of TGF-beta by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries. Int J Cardiol. 2010;145(3):468\u201375.","journal-title":"Int J Cardiol"},{"issue":"5","key":"409_CR33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1089\/hum.2013.105","volume":"25","author":"CE Appleby","year":"2014","unstructured":"Appleby CE, Ranjzad P, Williams PD, et al. Periluminal expression of a secreted transforming growth factor-beta type II receptor inhibits in-stent neointima formation following adenovirus-mediated stent-based intracoronary gene transfer. Hum Gene Ther. 2014;25(5):443\u201351.","journal-title":"Hum Gene Ther"},{"issue":"8","key":"409_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.tcm.2007.09.001","volume":"17","author":"AC Newby","year":"2007","unstructured":"Newby AC. Metalloproteinases and vulnerable atherosclerotic plaques. Trends Cardiovasc Med. 2007;17(8):253\u20138.","journal-title":"Trends Cardiovasc Med"},{"key":"409_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/VHRM.S68415","volume":"11","author":"TP Vacek","year":"2015","unstructured":"Vacek TP, Rehman S, Neamtu D, Yu S, Givimani S, Tyagi SC. Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms. Vasc Health Risk Manag. 2015;11:173\u201383.","journal-title":"Vasc Health Risk Manag"},{"issue":"2","key":"409_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1161\/01.ATV.19.2.255","volume":"19","author":"A Kranzhofer","year":"1999","unstructured":"Kranzhofer A, Baker AH, George SJ, Newby AC. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein. Arterioscler Thromb Vasc Biol. 1999;19(2):255\u201365.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"409_CR37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/01.CIR.101.3.296","volume":"101","author":"SJ George","year":"2000","unstructured":"George SJ, Lloyd CT, Angelini GD, Newby AC, Baker AH. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. Circulation. 2000;101(3):296\u2013304.","journal-title":"Circulation"},{"issue":"4","key":"409_CR38","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1161\/01.ATV.0000157582.33180.a9","volume":"25","author":"TW Johnson","year":"2005","unstructured":"Johnson TW, Wu YX, Herdeg C, et al. Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries. Arterioscler Thromb Vasc Biol. 2005;25(4):754\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11 Suppl","key":"409_CR39","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1161\/CIRCULATIONAHA.110.012732","volume":"124","author":"SJ George","year":"2011","unstructured":"George SJ, Wan S, Hu J, MacDonald R, Johnson JL, Baker AH. Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy. Circulation. 2011;124(11 Suppl):S135\u201342.","journal-title":"Circulation"},{"issue":"4","key":"409_CR40","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","volume":"120","author":"U Forstermann","year":"2017","unstructured":"Forstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017;120(4):713\u201335.","journal-title":"Circ Res"},{"issue":"4","key":"409_CR41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.niox.2006.03.011","volume":"15","author":"C Napoli","year":"2006","unstructured":"Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro LJ. Nitric oxide and atherosclerosis: an update. Nitric Oxide. 2006;15(4):265\u201379.","journal-title":"Nitric Oxide"},{"issue":"3","key":"409_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S1072-7515(98)00163-X","volume":"187","author":"LL Shears 2nd","year":"1998","unstructured":"Shears LL 2nd, Kibbe MR, Murdock AD, et al. Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J Am Coll Surg. 1998;187(3):295\u2013306.","journal-title":"J Am Coll Surg"},{"issue":"9","key":"409_CR43","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/01.CIR.98.9.919","volume":"98","author":"O Varenne","year":"1998","unstructured":"Varenne O, Pislaru S, Gillijns H, et al. Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation. 1998;98(9):919\u201326.","journal-title":"Circulation"},{"issue":"5 Pt 1","key":"409_CR44","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1525-0016(03)00061-3","volume":"7","author":"K Wang","year":"2003","unstructured":"Wang K, Kessler PD, Zhou Z, et al. Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model. Mol Ther. 2003;7(5 Pt 1):597\u2013603.","journal-title":"Mol Ther"},{"issue":"1","key":"409_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/jgm.1529","volume":"13","author":"LH Zhang","year":"2011","unstructured":"Zhang LH, Luo T, Zhang C, et al. Anti-DNA antibody modified coronary stent for plasmid gene delivery: results obtained from a porcine coronary stent model. J Gene Med. 2011;13(1):37\u201345.","journal-title":"J Gene Med"},{"issue":"4","key":"409_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/86490","volume":"7","author":"FL Celletti","year":"2001","unstructured":"Celletti FL, Waugh JM, Amabile PG, Brendolan A, Hilfiker PR, Dake MD. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med. 2001;7(4):425\u20139.","journal-title":"Nat Med"},{"issue":"4","key":"409_CR47","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/cvr\/cvt148","volume":"99","author":"SE Heinonen","year":"2013","unstructured":"Heinonen SE, Kivela AM, Huusko J, et al. The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models. Cardiovasc Res. 2013;99(4):716\u201323.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"409_CR48","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.cardiores.2003.09.003","volume":"60","author":"K Pels","year":"2003","unstructured":"Pels K, Deiner C, Coupland SE, et al. Effect of adventitial VEGF(165) gene transfer on vascular thickening after coronary artery balloon injury. Cardiovasc Res. 2003;60(3):664\u201372.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"409_CR49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2005.12.008","volume":"189","author":"C Deiner","year":"2006","unstructured":"Deiner C, Schwimmbeck PL, Koehler IS, et al. Adventitial VEGF165 gene transfer prevents lumen loss through induction of positive arterial remodeling after PTCA in porcine coronary arteries. Atherosclerosis. 2006;189(1):123\u201332.","journal-title":"Atherosclerosis"},{"issue":"1\u20132","key":"409_CR50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mrfmmm.2007.02.011","volume":"621","author":"J Mercer","year":"2007","unstructured":"Mercer J, Mahmoudi M, Bennett M. DNA damage, p53, apoptosis and vascular disease. Mutat Res. 2007;621(1\u20132):75\u201386.","journal-title":"Mutat Res"},{"issue":"8","key":"409_CR51","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1161\/hh0801.090536","volume":"88","author":"I Tabas","year":"2001","unstructured":"Tabas I. P53 and atherosclerosis. Circ Res. 2001;88(8):747\u20139.","journal-title":"Circ Res"},{"issue":"5","key":"409_CR52","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.ymthe.2004.02.005","volume":"9","author":"S Wan","year":"2004","unstructured":"Wan S, George SJ, Nicklin SA, Yim AP, Baker AH. Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein grafts. Mol Ther. 2004;9(5):689\u201398.","journal-title":"Mol Ther"},{"issue":"2","key":"409_CR53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijcard.2013.11.033","volume":"171","author":"Y Xiong","year":"2014","unstructured":"Xiong Y, Ren YF, Xu J, et al. Enhanced external counterpulsation inhibits endothelial apoptosis via modulation of BIRC2 and Apaf-1 genes in porcine hypercholesterolemia. Int J Cardiol. 2014;171(2):161\u20138.","journal-title":"Int J Cardiol"},{"issue":"6","key":"409_CR54","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nm0695-541","volume":"1","author":"C Indolfi","year":"1995","unstructured":"Indolfi C, Avvedimento EV, Rapacciuolo A, et al. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med. 1995;1(6):541\u20135.","journal-title":"Nat Med"},{"issue":"2","key":"409_CR55","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1006\/jsre.2000.6014","volume":"94","author":"G Jin","year":"2000","unstructured":"Jin G, Chieh-Hsi Wu J, Li YS, Hu YL, Shyy JY, Chien S. Effects of active and negative mutants of Ras on rat arterial neointima formation. J Surg Res. 2000;94(2):124\u201332.","journal-title":"J Surg Res"},{"issue":"1","key":"409_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/jsre.2001.6159","volume":"99","author":"CH Wu","year":"2001","unstructured":"Wu CH, Lin CS, Hung JS, et al. Inhibition of neointimal formation in porcine coronary artery by a Ras mutant. J Surg Res. 2001;99(1):100\u20136.","journal-title":"J Surg Res"},{"issue":"21","key":"409_CR57","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1161\/01.CIR.0000070540.80780.92","volume":"107","author":"M Hedman","year":"2003","unstructured":"Hedman M, Hartikainen J, Syvanne M, et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation. 2003;107(21):2677\u201383.","journal-title":"Circulation"},{"issue":"5","key":"409_CR58","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/gt.2009.4","volume":"16","author":"M Hedman","year":"2009","unstructured":"Hedman M, Muona K, Hedman A, et al. Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer. Gene Ther. 2009;16(5):629\u201334.","journal-title":"Gene Ther"},{"issue":"16","key":"409_CR59","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1161\/01.CIR.0000093398.16124.29","volume":"108","author":"S Rajagopalan","year":"2003","unstructured":"Rajagopalan S, Mohler ER 3rd, Lederman RJ, et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation. 2003;108(16):1933\u20138.","journal-title":"Circulation"},{"issue":"1","key":"409_CR60","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/mthe.2002.0638","volume":"6","author":"K Makinen","year":"2002","unstructured":"Makinen K, Manninen H, Hedman M, et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther. 2002;6(1):127\u201333.","journal-title":"Mol Ther"},{"key":"409_CR61","doi-asserted-by":"crossref","unstructured":"Robertson KE, McDonald RA, Oldroyd KG, Nicklin SA, Baker AH. Prevention of coronary in-stent restenosis and vein graft failure: does vascular gene therapy have a role? Pharmacol Ther. 2012;136(1):23\u201334.","DOI":"10.1016\/j.pharmthera.2012.07.002"},{"issue":"5","key":"409_CR62","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/ATVBAHA.111.237693","volume":"32","author":"GS Getz","year":"2012","unstructured":"Getz GS, Reardon CA. Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(5):1104\u201315.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"409_CR63","doi-asserted-by":"publisher","first-page":"126","DOI":"10.12998\/wjcc.v2.i5.126","volume":"2","author":"FR Kapourchali","year":"2014","unstructured":"Kapourchali FR, Surendiran G, Chen L, Uitz E, Bahadori B, Moghadasian MH. Animal models of atherosclerosis. World J Clin Cases. 2014;2(5):126\u201332.","journal-title":"World J Clin Cases"},{"key":"409_CR64","doi-asserted-by":"crossref","unstructured":"Lee YT, Lin HY, Chan YW et al. Mouse models of atherosclerosis: a historical perspective and recent advances. Lipids Health. Dis. 16(1), 12\u2013016\u20130402-5 (2017).","DOI":"10.1186\/s12944-016-0402-5"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-017-0409-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-017-0409-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-017-0409-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T18:35:06Z","timestamp":1589740506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-017-0409-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,13]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1007\/s13346-017-0409-0","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,13]]},"assertion":[{"value":"13 July 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no other relevant affiliations or financial involvement with any organization or entity with financial interest or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial and competing interests\u2019 disclosure"}}]}}